Stroke injury in rats causes an increase in activin A gene expression which is unaffected by oestradiol treatment

Journal of Neuroendocrinology

Volumn 18, Issue 2, 2006, Pages 97-103

  Böttner, Martina ^a   Dubal, D B ^b,d   Rau, S W ^b,e   Suzuki, S ^c   Wise, P M ^c  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Growth factors; Middle cerebral artery occlusion; Oestrogen; Stroke; TGF

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR 1; ESTRADIOL; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC CODE; HEMISPHERIC DOMINANCE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STROKE; UPREGULATION;

ACTIVIN RECEPTORS, TYPE I; ANALYSIS OF VARIANCE; ANIMALS; BRAIN DAMAGE, CHRONIC; CEREBRAL CORTEX; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; INHIBIN-BETA SUBUNITS; NEOSTRIATUM; NEURONS; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 33645859906     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2005.01384.x     Document Type: Article

References (63)

1. Kingsley DM. The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994; 8: 133-146.
2. Mathews LS, Vale WW. Characterization of type II activin receptors. Binding, processing, and phosphorylation. J Biol Chem 1993; 268: 19013-19018.
3. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998; 67: 753-791.
4. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D, Spiess J. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986; 321: 776-779.
5. Smith JC. Mesoderm-inducing factors and mesodermal patterning. Curr Opin Cell Biol 1995; 7: 856-861.
6. Jones KL, de Kretser DM, Patella S, Phillips DJ. Activin A and follistatin in systemic inflammation. Mol Cell Endocrinol 2004; 225: 119-125.
7. Chen YG, Lui HM, Lin SL, Lee JM, Ying SY. Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood) 2002; 227: 75-87.
8. Munz B, Hubner G, Tretter Y, Alzheimer C, Werner S. A novel role of activin in inflammation and repair. J Endocrinol 1999; 161: 187-193.
9. Tretter YP, Munz B, Hubner G, ten Bruggencate G, Werner S, Alzheimer C. Strong induction of activin expression after hippocampal lesion. Neuroreport 1996; 7: 1819-1823.
10. Lai M, Sirimanne E, Williams CE, Gluckman PD. Sequential patterns of inhibin subunit gene expression following hypoxic-ischemic injury in the rat brain. Neuroscience 1996; 70: 1013-1024.
11. Hughes PE, Alexi T, Williams CE, Clark RG, Gluckman PD. Administration of recombinant human activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease. Neuroscience 1999; 92: 197-209.
12. Krieglstein K, Suter-Crazzolara C, Fischer WH, Unsicker K. TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J 1995; 14: 736-742.
13. Tretter YP, Hertel M, Munz B, ten Bruggencate G, Werner S, Alzheimer C. Induction of activin A is essential for the neuroprotective action of basic fibroblast growth factor in vivo. Nat Med 2000; 6: 812-815.
14. Toran-Allerand CD. Sex steroids and the development of the newborn mouse hypothalamus and preoptic area in vitro: Implications for sexual differentiation. Brain Res 1976; 106: 407-412.
15. Reisert I, Han V, Lieth E, Toran-Allerand D, Pilgrim C, Lauder J. Sex steroids promote neurite growth in mesencephalic tyrosine hydroxylase immunoreactive neurons in vitro. Int J Dev Neurosci 1987; 5: 91-98.
16. Hurn PD, Macrae IM. Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab 2000; 20: 631-652.
17. Yang SH, Shi J, Day AL, Simpkins JW. Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 2000; 31: 745-749.
18. Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol. Prog Neurobiol 2001; 63: 29-60.
19. Carrer HF, Cambiasso MJ. Sexual differentiation of the brain: Genes, estrogen, and neurotrophic factors. Cell Mol Neurobiol 2002; 22: 479-500.
20. Wise PM. Estrogens and neuroprotection. Trends Endocrinol Metab 2002; 13: 229-230.
21. Maggi A, Ciana P, Belcredito S, Vegeto E. Estrogens in the nervous system: Mechanisms and nonreproductive functions. Annu Rev Physiol 2004; 66: 291-313.
22. Soma KK, Tramontin AD, Featherstone J, Brenowitz EA. Estrogen contributes to seasonal plasticity of the adult avian song control system. J Neurobiol 2004; 58: 413-422.
23. Singer CA, Rogers KL, Strickland TM, Dorsa DM. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci Lett 1996; 212: 13-16.
24. Bonnefont AB, Munoz FJ, Inestrosa NC. Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes. FEBS Lett 1998; 441: 220-224.
25. Sawada H, Ibi M, Kihara T, Urushitani M, Akaike A, Shimohama S. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J Neurosci Res 1998; 54: 707-719.
26. Wilson ME, Dubal DB, Wise PM. Estradiol protects against injury-induced cell death in cortical explant cultures: A role for estrogen receptors. Brain Res 2000; 873: 235-242.
27. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD. Gender-linked brain injury in experimental stroke. Stroke 1998; 29: 159-165.
28. Simpkins JW, Rajakumar G, Zhang YQ, Simpkins CE, Greenwald DYuCJ, Bodor N, Day AL. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 1997; 87: 724-730.
29. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 1998; 18: 1253-1258.
30. Dubal DB, Wise PM. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 2001; 142: 43-48.
31. Rau SW, Dubal DB, Böttner M, Gerhold LM, Wise PM. Estradiol attenuates markers of programmed cell death after focal cerebral ischemia. J Neurosci 2003; 23: 11420-11426.
32. Wilson ME, Liu Y, Wise PM. Estradiol enhances Akt activation in cortical explant cultures following neuronal injury. Brain Res Mol Brain Res 2002; 102: 48-54.
33. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986; 17: 1304-1308.
34. Chomczynski P, Sacchi N. Single-step methods of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
35. Ogawa K, Abe K, Kurosawa N, Kurohmaru M, Sugino H, Takahashi M, Hayashi Y. Expression of alpha, beta A and beta B subunits of inhibin or activin and follistatin in rat pancreatic islets. FEBS Lett 1993; 319: 217-220.
36. Hoshimaru M, Ray J, Sah DWY, Gage FH. Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene. Proc Natl Acad Sci USA 1996; 963: 1518-1523.
37. Andreasson K, Worley PF. Induction of beta-A activin expression by synaptic activity and during neocortical development. Neuroscience 1995; 69: 781-796.
38. Schubert D, Kimura H, LaCorbiere M, Vaughan J, Karr D, Fischer WH. Activin is a nerve cell survival molecule. Nature 1990; 344: 868-870.
39. Iwahori Y, Saito H, Torii K, Nishiyama N. Activin exerts a neurotrophic effect on cultured hippocampal neurons. Brain Res 1997; 760: 52-58.
40. Lai M, Gluckman P, Dragunow M, Hughes PE. Focal brain injury increases activin betaA mRNA expression in hippocampal neurons. Neuroreport 1997; 8: 2691-2694.
41. Wu DD, Lai M, Hughes PE, Sirimanne E, Gluckman PD, Williams CE. Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. Brain Res 1999; 835: 369-378.
42. Foster JA, Puchowicz MJ, McIntyre DC, Herkenham M. Activin mRNA induced during amygdala kindling shows a spatiotemporal progression that tracks the spread of seizures. J Comp Neurol 2004; 476: 91-102.
43. Massague J, Weis-Garcia F. Serine/threonine kinase receptors: Mediators of transforming growth factor beta family signals. Cancer Surv 1996; 27: 41-64.
44. Josso N, di Clemente N. Serine/threonine kinase receptors and ligands. Curr Opin Genet Dev 1997; 7: 371-377.
45. Michel U, Gerber JE, O'Connor A, Bunkowski S, Bruck W, Nau R, Phillips DJ. Increased activin levels in cerebrospinal fluid of rabbits with bacterial meningitis are associated with activation of microglia. J Neurochem 2003; 86: 238-245.
46. Lewen A, Soderstrom S, Hillered L, Ebendal T. Expression of serine/ threonine kinase receptors in traumatic brain injury. Neuroreport 1997; 8: 475-479.
47. Cruise BA, Xu P, Hall AK. Wounds increase activin in skin and a vasoactive neuropeptide in sensory ganglia. Dev Biol 2004; 271: 1-10.
48. Munz B, Tretter YP, Hertel M, Engelhardt F, Alzheimer C, Werner S. The roles of activins in repair processes of the skin and the brain. Mol Cell Endocrinol 2001; 180: 169-177.
49. Ohguchi M, Yamato K, Ishihara Y, Koide M, Ueda N, Okahashi N, Noguchi T, Kizaki M, Ikeda Y, Sugino H, Nisihara T. Activin A regulates the production of mature interleukin-1beta and interleukin-1 receptor antagonist in human monocytic cells. J Interferon Cytokine Res 1998; 18: 491-498.
50. Yu, J, Dolter KE. Production of activin A and its roles in inflammation and hematopoiesis. Cytokines Cell Mol Ther 1997; 3: 169-177.
51. Russell CE, Hedger MP, Brauman JN, de Kretser DM, Phillips DJ. Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2. Mol Cell Endocrinol 1999; 148: 129-136.
52. Tatlisumak T, Takano K, Carano RA, Fisher M. Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and perfusion imaging. Stroke 1996; 27: 2292-2297.
53. Ay I, Sugimori H, Finklestein SP. Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats. Brain Res Mol Brain Res 2001; 87: 71-80.
54. Fujiwara K, Date I, Shingo T, Yoshida H, Kobayashi K, Takeuchi A, Yano A, Tamiya T, Ohmoto T. Reduction of infarct Volume and apoptosis by grafting of encapsulated basic fibroblast growth factor-secreting cells in a model of middle cerebral artery occlusion in rats. J Neurosurg 2003; 99: 1053-1062.
55. Alzheimer C, Werner S. Fibroblast growth factors and neuroprotection. Adv Exp Med Biol 2002; 513: 335-351.
56. Djurovic S, Os I, Hofstad AE, Abdelnoor M, Westheim A, Berg K, Abdelonoor M. Increased plasma concentrations of TGF-beta1 after hormone replacement therapy. J Intern Med 2000; 247: 279-185.
57. Ashcroft GS, Dodsworth J, van Boxtel E, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 1997; 3: 209-1215.
58. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 1996; 2: 1132-1136.
59. Muttukrishna S, Fowler PA, George L, Groome NP, Knight PG. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J Clin Endocrinol Metab 1996; 81: 3328-3334.
60. Arai KY, Ohshima K, Watanabe G, Arai K, Uehara K, Taya K. Dynamics of messenger RNAs encoding inhibin/activin subunits and follistatin in the ovary during the rat estrous cycle. Biol Reprod 2002; 66: 1119-1126.
61. Carpenter KD, Hayashi K, Spencer TE. Ovarian regulation of endometrial gland morphogenesis and activin-follistatin system in the neonatal ovine uterus. Biol Reprod 2003; 69: 851-860.
62. Tate S, Suganuma N, Furuhashi M, Ando T, Asada Y, Kondo I, Kikkawa F, Tomoda Y. Direct effects of estradiol and tamoxifen on gene expressions of inhibit alpha- and beta A-subunits in rat granulosa cells in vitro. Endocr J 1996; 43: 621-628.
63. Billiar RB, Zachos NC, Burch MG, Albrecht ED, Pepe GJ. Up-regulation of alpha-inhibin expression in the fetal ovary of estrogen-suppressed baboons is associated with impaired fetal ovarian folliculogenesis. Biol Reprod 2003; 68: 1989-1996.